Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies.
ÂgeExpression génétique
#3
Le tabagisme affecte-t-il Wnt-5a ?
Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer.
TabagismeRisque de cancer
#4
Y a-t-il un lien entre l'alimentation et Wnt-5a ?
Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a.
AlimentationGraisses alimentaires
#5
Le stress chronique impacte-t-il Wnt-5a ?
Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies.
Stress chroniqueRégulation hormonale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéine Wnt-5a : Questions médicales les plus fréquentes",
"headline": "Protéine Wnt-5a : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéine Wnt-5a : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-28",
"dateModified": "2025-04-23",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de type Wingless",
"url": "https://questionsmedicales.fr/mesh/D051153",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de type Wingless",
"code": {
"@type": "MedicalCode",
"code": "D051153",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.984"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéine Wnt-5a",
"alternateName": "Wnt-5a Protein",
"code": {
"@type": "MedicalCode",
"code": "D000071818",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Soon B Hwang",
"url": "https://questionsmedicales.fr/author/Soon%20B%20Hwang",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of RNA Viral Diseases, Korea Zoonosis Research Institute, Chonbuk National University, Iksan, South Korea sbhwang@jbnu.ac.kr."
}
},
{
"@type": "Person",
"name": "Rui Zhou",
"url": "https://questionsmedicales.fr/author/Rui%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China."
}
},
{
"@type": "Person",
"name": "Xiang-Dong Li",
"url": "https://questionsmedicales.fr/author/Xiang-Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn."
}
},
{
"@type": "Person",
"name": "Richa Mishra",
"url": "https://questionsmedicales.fr/author/Richa%20Mishra",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
},
{
"@type": "Person",
"name": "Soumendra Rana",
"url": "https://questionsmedicales.fr/author/Soumendra%20Rana",
"affiliation": {
"@type": "Organization",
"name": "Chemical Biology Laboratory, School of Basic Sciences, Indian Institute of Technology Bhubaneswar, Bhubaneswar, Odisha, India."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Visual Field Coordinate Systems in Visual Neurophysiology.",
"datePublished": "2023-05-08",
"url": "https://questionsmedicales.fr/article/37162088",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/0001-3765202320220381"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual Fields in Epidemic Retinitis.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35708453",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/09273948.2022.2084422"
}
},
{
"@type": "ScholarlyArticle",
"name": "Visual field asymmetries in numerosity processing.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36258143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3758/s13414-022-02585-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessment of visual field progression in glaucoma.",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36378107",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICU.0000000000000932"
}
},
{
"@type": "ScholarlyArticle",
"name": "Performance of VisuALL virtual reality visual field testing in healthy children.",
"datePublished": "2024-01-14",
"url": "https://questionsmedicales.fr/article/38219921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaapos.2023.10.004"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de type Wingless",
"item": "https://questionsmedicales.fr/mesh/D051153"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéine Wnt-5a",
"item": "https://questionsmedicales.fr/mesh/D000071818"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéine Wnt-5a - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéine Wnt-5a",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéine Wnt-5a",
"description": "Comment diagnostiquer une anomalie de Wnt-5a ?\nQuels tests sont utilisés pour mesurer Wnt-5a ?\nWnt-5a est-il lié à des maladies spécifiques ?\nPeut-on détecter Wnt-5a dans le sang ?\nQuels biomarqueurs sont associés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéine Wnt-5a",
"description": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?\nWnt-5a influence-t-il le cancer ?\nY a-t-il des signes cliniques de dysfonction de Wnt-5a ?\nWnt-5a affecte-t-il le système nerveux ?\nQuels effets sur la peau sont liés à Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéine Wnt-5a",
"description": "Peut-on prévenir les anomalies de Wnt-5a ?\nY a-t-il des facteurs environnementaux affectant Wnt-5a ?\nComment le mode de vie influence-t-il Wnt-5a ?\nLes suppléments nutritionnels aident-ils Wnt-5a ?\nLa gestion du stress influence-t-elle Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéine Wnt-5a",
"description": "Comment traiter les anomalies de Wnt-5a ?\nY a-t-il des médicaments ciblant Wnt-5a ?\nLa thérapie génique peut-elle aider Wnt-5a ?\nQuels traitements sont efficaces contre le cancer lié à Wnt-5a ?\nDes essais cliniques existent-ils pour Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéine Wnt-5a",
"description": "Quelles complications sont liées à Wnt-5a ?\nWnt-5a peut-il causer des troubles métaboliques ?\nY a-t-il des risques de récidive de cancer avec Wnt-5a ?\nWnt-5a influence-t-il la réponse immunitaire ?\nDes complications neurologiques sont-elles possibles avec Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéine Wnt-5a",
"description": "Quels sont les facteurs de risque pour Wnt-5a ?\nL'âge influence-t-il Wnt-5a ?\nLe tabagisme affecte-t-il Wnt-5a ?\nY a-t-il un lien entre l'alimentation et Wnt-5a ?\nLe stress chronique impacte-t-il Wnt-5a ?",
"url": "https://questionsmedicales.fr/mesh/D000071818?mesh_terms=Visual+Fields#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie de Wnt-5a ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses de tissus peuvent être utilisés pour évaluer les niveaux de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer Wnt-5a ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages ELISA et des techniques de Western blot sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Wnt-5a est-il lié à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a sont associées à des cancers et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Peut-on détecter Wnt-5a dans le sang ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux de Wnt-5a peuvent être mesurés dans le sérum sanguin."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à Wnt-5a ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "D'autres protéines de la voie Wnt, comme Wnt-1 et β-caténine, peuvent être des biomarqueurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à une dysrégulation de Wnt-5a ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de développement, des troubles immunitaires et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il le cancer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est liée à la progression de certains cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques de dysfonction de Wnt-5a ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des malformations congénitales et des troubles de la croissance peuvent être observés."
}
},
{
"@type": "Question",
"name": "Wnt-5a affecte-t-il le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a joue un rôle dans le développement neuronal et peut affecter la neurogenèse."
}
},
{
"@type": "Question",
"name": "Quels effets sur la peau sont liés à Wnt-5a ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies de Wnt-5a peuvent entraîner des troubles cutanés et des cancers de la peau."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de Wnt-5a ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne santé maternelle et des soins prénatals appropriés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux affectant Wnt-5a ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines et à des perturbateurs endocriniens peut influencer Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il Wnt-5a ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut soutenir la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels aident-ils Wnt-5a ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments, comme les acides gras oméga-3, peuvent moduler l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "La gestion du stress influence-t-elle Wnt-5a ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut avoir un impact positif sur la régulation de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Comment traiter les anomalies de Wnt-5a ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies ciblées et des traitements immunologiques peuvent être envisagés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments ciblant Wnt-5a ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des inhibiteurs de la voie Wnt sont en développement pour traiter certains cancers."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider Wnt-5a ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger les anomalies de Wnt-5a dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre le cancer lié à Wnt-5a ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements combinés de chimiothérapie et d'immunothérapie montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Des essais cliniques existent-ils pour Wnt-5a ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, plusieurs essais cliniques évaluent des traitements ciblant la voie Wnt-5a."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à Wnt-5a ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des malformations congénitales et des cancers avancés."
}
},
{
"@type": "Question",
"name": "Wnt-5a peut-il causer des troubles métaboliques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysrégulation de Wnt-5a peut contribuer à des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de récidive de cancer avec Wnt-5a ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une expression anormale de Wnt-5a est associée à un risque accru de récidive."
}
},
{
"@type": "Question",
"name": "Wnt-5a influence-t-il la réponse immunitaire ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, Wnt-5a peut moduler la réponse immunitaire, affectant la susceptibilité aux infections."
}
},
{
"@type": "Question",
"name": "Des complications neurologiques sont-elles possibles avec Wnt-5a ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies de Wnt-5a peuvent entraîner des complications neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour Wnt-5a ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il Wnt-5a ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge peut affecter l'expression de Wnt-5a et son rôle dans diverses pathologies."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il Wnt-5a ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer l'expression de Wnt-5a, augmentant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien entre l'alimentation et Wnt-5a ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses peut influencer négativement l'expression de Wnt-5a."
}
},
{
"@type": "Question",
"name": "Le stress chronique impacte-t-il Wnt-5a ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la régulation de Wnt-5a, augmentant les risques de maladies."
}
}
]
}
]
}
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
University of Chinese Academy of Sciences, Beijing 100049, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China lixd@ioz.ac.cn.
University of Chinese Academy of Sciences, Beijing 100049, China.
Departamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile; Centro de Excelencia en Biomedicina de Magallanes (CEBIMA), Escuela de Medicina, Universidad de Magallanes, Punta Arenas, Chile. Electronic address: ninestrosa@bio.puc.cl.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Group of Cell Motility and Muscle Contraction, State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
University of Chinese Academy of Sciences, Beijing, China.
In this work, algorithms have been developed to: 1. Compare visual field coordinate data, presented in different representation systems; 2. Determine the distance in degrees between any two points in ...
The aim of the study is to analyze visual fields defects (VFDs) in epidemic retinitis (ER)....
Patients with ER and Humphrey's visual field (HFA) 30-2 performed after resolution were studied. VFD severity grading was performed. Patients treated with oral doxycycline (Group-A) versus doxycycline...
Thirty-five eyes of 25 patients were studied. Nasal, inferior, temporal and central VFD were seen in 19 (54.2%), 13 (37.1%), 7 (20%) and 6 (17.1%) eyes, respectively. Grade 0, 1, 2 and 3 VFDs were see...
ER can cause VFD persisting long after resolution. Treatment with oral doxycycline without steroids was non-inferior to combined treatment with respect to VFD....
A small number of objects can be rapidly and accurately enumerated, whereas a larger number of objects can only be approximately enumerated. These subitizing and estimation abilities, respectively, ar...
Perimetry plays an important role in the diagnosis and management of glaucoma. This article discusses the assessment of visual field progression in patients with glaucoma....
Selecting the best visual field test strategy and establishing a baseline of visual fields will assist clinicians in the detection of glaucomatous progression. Repeat testing serves to confirm or refu...
Many treated patients with glaucoma will experience visual field progression. Optimal utilization of visual field testing strategy and analytical software can help clinicians identify patients with gl...
Virtual reality field testing may provide an alternative to standard automated perimetry. This study evaluates a virtual reality game-based automated perimetry in a healthy pediatric population....
A prospective series of pediatric patients at one institution who performed VisuALL perimetry (Olleyes Inc, Summit, NJ) using a game-based algorithm. Participants were examined by an experienced pedia...
A total of 191 eyes of 97 patients (54% female) were included, with a mean age of 11.9 ± 3.1 years. The average MD was -1.82 ± 3.5 dB, with a mean foveal sensitivity of 32.0 ± 4.7 dB. Fifty-nine eyes ...
VisuALL virtual reality field testing was well tolerated in this pediatric study cohort. Older age and shorter test duration were associated with better performance on field testing....
Perimetry is widely used in the localization of retrochiasmal visual pathway lesions. Although macular sparing, homonymous paracentral scotomas, and quadrantanopias are regarded as features of posteri...
Retrospective record review conducted in a single, academic, medical center using an electronic search engine with the terms ""homonymous hemianopia," "optic tract," "temporal lobectomy," "visual fiel...
From an original cohort of 256 cases, only 83 had MRI-defined lesions that were limited to particular retrochiasmal segments and had visual field defect patterns that allegedly permitted localization ...
In correlating discrete MRI-defined retrochiasmal lesions with visual field defect patterns identified on static perimetry, this study showed that macular sparing, homonymous paracentral scotomas, and...
To compare visual field test results of Glaufield Lite AP901 CTS 133 (Appasamy Associates, Mannadipet Commune, Thirubhuvanai, Puducherry, India, hereafter Glaufield Lite) with Humphrey Field Analyser ...
A pilot study at a tertiary eye centre involving 23 normal and 24 glaucoma patients who underwent two consecutive visual field tests on (i) HFA 24-2 SITA Fast and (ii) Glaufield Lite Quick Central pro...
The mean testing time on HFA was significantly shorter than Glaufield Lite (normals: HFA: 2.75 ± 0.49 min, Glaufield Lite: 6.85 ± 0.86 min, p < 0.001; glaucoma patients: HFA: 3.45 ± 1.08 min, Glaufiel...
Both perimetric techniques showed reliable test results though test duration was longer with Glaufield Lite perimetry. The MD showed poor agreement, likely due to different scales and principles used ...
Identifying the clinical relevance of superficial versus deep layer macular vessel density (mVD) in glaucoma is important for monitoring glaucoma patients. Our current retrospective longitudinal study...
Visual fields are an integral part of glaucoma diagnosis and management. COVID has heightened the awareness of the potential for viral spread with the practice of visual fields modified. Mask artefact...
The tilt aftereffect (TAE) is observed when adaptation to a tilted contour alters the perceived tilt of a subsequently presented contour. Thus far, TAE has been treated as a local aftereffect observed...